Table 6.
Patients (n) | Survival (years) | Reference | ||||
---|---|---|---|---|---|---|
RA/RARS | RAEB | RAEB/T | MDS/AML | JMML | ||
48 MRD 52 MUD |
55% EFS (5) 49% EFS (5) |
Locatelli 2005 [145] |
||||
30 MRD, 27 MMRD, 30 MUD, 7 MMUD |
59% EFS (3) 74% OS (3) |
58%EFS (3) 68%OS (3) |
18% EFS (3) 18% OS (3) |
27% EFS (3) 33% OS (3) |
Yusuf 2004 [144] |
|
46 MUD | 24% DFS (2) | Smith 2002 [150] |
||||
9 MUD 3 MMRD |
64% EFS (3) | Bunin 1999 [149] |
||||
131 MRD | 52% DFS (5) 57% OS (5) |
34% DFS (5) 42% OS (5) |
19% DFS (5) 24% OS (5) |
26% DFS (5) 28% OS (5) |
Runde 1998 [148] |
|
60 MRD 19 MUD |
36% OS (4) 31% OS (4) |
Arico* 1997 [146] |
||||
14 MRD, 1 MMRD, 7 MUD, 2 MMUD (2nd SCT) |
32% DFS (5) | Yoshimi 2007 [147] |
MRD = matched related donor, MMRD = mismatched related donor, MUD = matched unrelated donor, MMUD = mismatched unrelated donor
review article